Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 720-726

  Zhang, Chao ^a   Liang, Ting ^a   Song, Jing ^a   Jiang, Shiqin ^a   Qu, Lili ^a   Hou, Guihua ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Anti MIF McAb; immunohistochemistry; MIF; radioiodine; RT PCR; tumor imaging

Indexed keywords

IMMUNOGLOBULIN G; IODINE 131; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVALUATION; GAMMA RADIATION; GENE EXPRESSION; IMAGING; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, SCID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79955975053     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.568517     Document Type: Article

References (19)

1. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105: 488-94. (Pubitemid 23213535)
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127: S5-16. (Pubitemid 39423365)
3. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89-97. (Pubitemid 36799110)
4. Braga FJ, Flamen P, Mortelmans L, Stroobants S, Homans F, Maes A. Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma. Clin Nucl Med 2001;27:642-5.
5. Leu H, Kleemann R. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002;4:449-60. (Pubitemid 34270682)
6. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49. (Pubitemid 30408719)
7. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800. (Pubitemid 37328657)
8. Nguyen J, Vasinrapee P, Cook R, Surprenant E, Spieth M, Wilson M. Hepatocellular carcinoma with intravascular extension: Ga-67 scintigraphic findings. Clin Nucl Med 1998;23:171-82.
9. Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 2006;5:399-410.
10. Lan HY. Role of macrophage migration inhibition factor in kidney disease. Nephron Exp Nephrol 2008;109: 79-83.
11. Brown FG, Nikolic-Paterson DJ, Metz C, Bucala R, Atkins RC, Lan HY. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 1999;118: 329-36. (Pubitemid 29519268)
12. Lolis E, Bucala R. Macrophage migration inhibitory factor. Expert Opin Ther Targets 2003;7:153-64. (Pubitemid 36512017)
13. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181-91. (Pubitemid 29252666)
14. Robinson P. Hepatocellular carcinoma: development and early detection. Cancer 2008;4:128-31.
15. Khawli LA, Biela B, Hu P, Epstein AL.Comparison of recombinant derivatives Of chimericTNT-3 antibody for the radioimaging of solid tumors. Hybrid Hybridomics 2003;22:1-9. (Pubitemid 36458230)
16. Datz FL, Anderson CE, Ahluwalia RJ. The efficacy of indium-111-polyclonal IgG for the detection of infection and inflammation. J Nucl Med 1994;35:74-83. (Pubitemid 24018445)
17. Akbar SM, Abe M, Murakami H. Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett 2001;171:125-32. (Pubitemid 32772798)
18. Nishio Y, Nishihira J, Ishibashi T. Role of macrophage migration inhibitory factor (MIF) in peripheral nerve regeneration: anti-MIF antibody induces delay of nerve regeneration and the apoptosis of Schwann cells. Mol Med 2002;8: 509-20. (Pubitemid 36332362)
19. Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitor factor-novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol 2006;6:1527-34. (Pubitemid 44216204)